BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34656 related articles for article (PubMed ID: 19081451)

  • 21. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary validation of the French translation of anxiety sensibility index-revised (ASI-R)].
    Bouvard M; Ayxères-Vighetto A; Dupont H; Aupetit J; Portalier S; Arrindell W
    Encephale; 2003; 29(2):157-64. PubMed ID: 14567167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between psychopathology and cognitive functioning in schizophrenia.
    Bozikas VP; Kosmidis MH; Kioperlidou K; Karavatos A
    Compr Psychiatry; 2004; 45(5):392-400. PubMed ID: 15332203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurocognitive subtypes of schizophrenia according to performance at verbal fluency tasks].
    Robert PH; Thauby S; Migneco V; Chaix I; Caci H; Benoit M; Pringuey D; Darcourt G
    Encephale; 1996; 22(6):435-42. PubMed ID: 10901836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [French translation of the Chapman Social and Physical Anhedonia Questionnaire: validation of the French translation in controls and schizophrenic patients].
    Assouly-Besse F; Dollfus S; Petit M
    Encephale; 1995; 21(4):273-84. PubMed ID: 7588166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Failure effects and gender differences in perfectionism].
    Masson AM; Cadot M; Ansseau M
    Encephale; 2003; 29(2):125-35. PubMed ID: 14567164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive functions related to interpersonal problem-solving skills in schizophrenic patients compared with healthy subjects.
    Zanello A; Perrig L; Huguelet P
    Psychiatry Res; 2006 May; 142(1):67-78. PubMed ID: 16631929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verbal fluency in schizophrenia: does cognitive performance reflect the same underlying mechanisms in patients and healthy controls?
    Ojeda N; Sánchez P; Peña J; Elizagárate E; Yoller AB; Larumbe J; Gutiérrez M; Casais L; Ezcurra J
    J Nerv Ment Dis; 2010 Apr; 198(4):286-91. PubMed ID: 20386258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder.
    Chianetta JM; Lefebvre M; LeBlanc R; Grignon S
    Schizophr Res; 2008 Oct; 105(1-3):86-94. PubMed ID: 18790606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
    Sarolta K; Pál C; István B
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
    Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
    Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
    Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
    Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
    Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 1733.